Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studySusan E. Dorman, Samuel G. Schumacher, David Alland et al.|The Lancet Infectious Diseases|2017Cited by 688
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportBorisov Se, Valentina Marchese, Qingshan Cai et al.|European Respiratory Journal|2019Cited by 176
The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and AnalysisAlex Rosenthal, Michael Tartakovsky, Andrei Gabrielian et al.|Journal of Clinical Microbiology|2017Cited by 140
Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in BelarusKurt Wollenberg, Ashlee M. Earl, Christopher A. Desjardins et al.|Journal of Clinical Microbiology|2016Cited by 63
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort studyOleksandr Korotych, Askar Yedilbayev, Jay Achar et al.|The Lancet Infectious Diseases|2024Cited by 23